Lysogene, a phase 3 gene therapy platform Company targeting central nervous system (CNS) diseases, announced that it has secured a €4.3 million non-dilutive financing...
Gynov ("the Company"), a French company that designs, manufactures and markets innovative nutritional supplements, Food for Special Medical Purposes (DADFMS) and medical devices for...
CytoDyn Inc., a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, reported data from its trial treating...
Ursa Space Systems, a US-based satellite intelligence company, announced today it joined the Amazon Web Services (AWS) Partner Network (APN), a global community of...
According to the report from TechOrange, a subsidiary company of Fusionmedium, following Foxconn's release of three EV prototypes in early October, Taiwan's high-tech industry...
